ETERNOX
®
First in Class
Catalytic Blood Purification
ROS Storm Control
First in Class
Catalytic Blood Purification
ROS Storm Control
The world's first catalytic extracorporeal ROS-targeted platform, redefining the paradigm of septic shock treatment.
The world's first catalytic extracorporeal ROS-targeted platform, redefining the paradigm of septic shock treatment.
The world's first catalytic extracorporeal ROS-targeted platform, redefining the paradigm of septic shock treatment.
We make survival a matter of engineering, not chance.
We make survival a matter of engineering, not chance.
Why It Matters
Sepsis claims 11 million lives every year.
Sepsis claims 11 million lives every year.
Sepsis claims 11 million lives every year.
A global crisis persisting for over two decades! Yet, the treatment paradigm remains fundamentally unchanged.
A global crisis persisting for over two decades! Yet, the treatment paradigm remains fundamentally unchanged.
A global crisis persisting for over two decades! Yet, the treatment paradigm remains fundamentally unchanged.
Annual Deaths
,
M
Approximately 11 million people die from sepsis annually, generating over $62 billion in healthcare costs in U.S. ICUs alone.
Annual Deaths
M
Approximately 11 million people die from sepsis annually, generating over $62 billion in healthcare costs in U.S. ICUs alone.
Annual Deaths
M
Approximately 11 million people die from sepsis annually, generating over $62 billion in healthcare costs in U.S. ICUs alone.
Annual Deaths
M
Approximately 11 million people die from sepsis annually, generating over $62 billion in healthcare costs in U.S. ICUs alone.
Septic Shock Mortality Rate
~
%
Despite standard of care, the mortality rate for patients with septic shock remains stubbornly high at 30–40%.
Septic Shock Mortality Rate
~
%
Despite standard of care, the mortality rate for patients with septic shock remains stubbornly high at 30–40%.
Septic Shock Mortality Rate
~
%
Despite standard of care, the mortality rate for patients with septic shock remains stubbornly high at 30–40%.
Global Cause of Death
%
Sepsis is one of the most fatal global health crises, accounting for approximately 20% of all deaths worldwide.
Global Cause of Death
%
Sepsis is one of the most fatal global health crises, accounting for approximately 20% of all deaths worldwide.
Global Cause of Death
%
Sepsis is one of the most fatal global health crises, accounting for approximately 20% of all deaths worldwide.
Technology
Targeting the Upstream Cause, Not Just the Symptoms
Targeting the Upstream Cause, Not Just the Symptoms
Targeting the Upstream Cause, Not Just the Symptoms
ROSorber™ directly eliminates ROS from the circulating blood, tackling the root cause of septic shock.
ROSorber™ directly eliminates ROS from the circulating blood, tackling the root cause of septic shock.
ROSorber™ directly eliminates ROS from the circulating blood, tackling the root cause of septic shock.
Direct Elimination of Circulating ROS
By passing circulating blood through the ROSorber™ cartridge, it directly removes Reactive Oxygen Species (ROS) to fundamentally address the root cause of multi-organ failure driven by the 'ROS storm'.
Direct Elimination of Circulating ROS
By passing circulating blood through the ROSorber™ cartridge, it directly removes Reactive Oxygen Species (ROS) to fundamentally address the root cause of multi-organ failure driven by the 'ROS storm'.
Direct Elimination of Circulating ROS
By passing circulating blood through the ROSorber™ cartridge, it directly removes Reactive Oxygen Species (ROS) to fundamentally address the root cause of multi-organ failure driven by the 'ROS storm'.
First-in-Class Nano-Catalytic Platform
The world’s first blood purification platform utilizing Ceria Nanoparticle (CeNP)-immobilized microbeads fundamentally differs from conventional simple adsorption methods. Driven by an auto-regenerative catalytic reaction, it infinitely and repeatedly eliminates ROS without ever being depleted.
First-in-Class Nano-Catalytic Platform
The world’s first blood purification platform utilizing Ceria Nanoparticle (CeNP)-immobilized microbeads fundamentally differs from conventional simple adsorption methods. Driven by an auto-regenerative catalytic reaction, it infinitely and repeatedly eliminates ROS without ever being depleted.
First-in-Class Nano-Catalytic Platform
The world’s first blood purification platform utilizing Ceria Nanoparticle (CeNP)-immobilized microbeads fundamentally differs from conventional simple adsorption methods. Driven by an auto-regenerative catalytic reaction, it infinitely and repeatedly eliminates ROS without ever being depleted.
Product
Engineering-Driven Core Technology
Engineering-Driven Core Technology
The World’s First Non-Saturating ROS Control Platform Powered by Auto-Regenerative Ceria Nanocatalysts
The World’s First Non-Saturating ROS Control Platform Powered by Auto-Regenerative Ceria Nanocatalysts
Ultra-Fast Catalytic ROS Neutralization
Ultra-Fast Catalytic ROS Neutralization
We have transcended the limitations of conventional filters that quickly saturate through simple adsorption. Powered by the catalytic action of ceria nanoparticles, this innovative blood purification platform continuously regenerates and neutralizes reactive oxygen species (ROS) without depletion.
Ultra-Fast Catalytic ROS Neutralization
Ultra-Fast Catalytic ROS Neutralization
We have transcended the limitations of conventional filters that quickly saturate through simple adsorption. Powered by the catalytic action of ceria nanoparticles, this innovative blood purification platform continuously regenerates and neutralizes reactive oxygen species (ROS) without depletion.
Overwhelming Systemic ROS Clearance
Unrivaled Systemic ROS Clearance
Taming the 'ROS storm' responsible for multi-organ failure requires macroscopic control at the systemic blood volume level. ROSorber™ processes hundreds of milliliters of blood per minute in real-time, delivering a powerful performance that instantly and massively reduces systemic ROS levels.
Overwhelming Systemic ROS Clearance
Unrivaled Systemic ROS Clearance
Taming the 'ROS storm' responsible for multi-organ failure requires macroscopic control at the systemic blood volume level. ROSorber™ processes hundreds of milliliters of blood per minute in real-time, delivering a powerful performance that instantly and massively reduces systemic ROS levels.
Seamless ICU Intergration
Seamless Clinical Integration
ROSorber™ instantly integrates with essential ICU extracorporeal circulation systems such as CRRT (Continuous Renal Replacement Therapy) and ECMO (Extracorporeal Membrane Oxygenation). Without the need for new capital equipment, it seamlessly fits into existing critical care protocols, enabling immediate emergency deployment within the golden hour.
Seamless ICU Intergration
Seamless Clinical Integration
ROSorber™ instantly integrates with essential ICU extracorporeal circulation systems such as CRRT (Continuous Renal Replacement Therapy) and ECMO (Extracorporeal Membrane Oxygenation). Without the need for new capital equipment, it seamlessly fits into existing critical care protocols, enabling immediate emergency deployment within the golden hour.
Application
Platform Innovation Driven by Clinical Needs
Platform Innovation Driven by Clinical Needs
ROSorber™ is designed to improve survival rates for septic shock patients in the ER and ICU. It seamlessly integrates with existing extracorporeal circulation systems, delivering a novel therapeutic approach that can be deployed within the golden hour.
ROSorber™ is designed to improve survival rates for septic shock patients in the ER and ICU. It seamlessly integrates with existing extracorporeal circulation systems, delivering a novel therapeutic approach that can be deployed within the golden hour.
ROSorber™ is designed to improve survival rates for septic shock patients in the ER and ICU. It seamlessly integrates with existing extracorporeal circulation systems, delivering a novel therapeutic approach that can be deployed within the golden hour.
ROSorber™ is designed to improve survival rates for septic shock patients in the ER and ICU. It seamlessly integrates with existing extracorporeal circulation systems, delivering a novel therapeutic approach that can be deployed within the golden hour.
Intensive Care Unit (ICU)
Suppresses the progression of multi-organ failure by providing real-time ROS control for patients in septic shock.
Intensive Care Unit (ICU)
Suppresses the progression of multi-organ failure by providing real-time ROS control for patients in septic shock.
Emergency Department (ED)
An early-intervention solution that directly neutralizes oxidative stress during the initial phases of care, mitigating the risk of progression to severe stages.
Emergency Department (ED)
An early-intervention solution that directly neutralizes oxidative stress during the initial phases of care, mitigating the risk of progression to severe stages.
Emergency Department (ED)
An early-intervention solution that directly neutralizes oxidative stress during the initial phases of care, mitigating the risk of progression to severe stages.
Emergency Department (ED)
An early-intervention solution that directly neutralizes oxidative stress during the initial phases of care, mitigating the risk of progression to severe stages.
A Scalable Platform Beyond Sepsis
A versatile extracorporeal blood purification platform expandable to other life-threatening conditions where explosive oxidative stress is the core pathology, including ARDS (Acute Respiratory Distress Syndrome), Post-Cardiac Arrest Syndrome (PCAS), and emerging infectious diseases.
A Scalable Platform Beyond Sepsis
A versatile extracorporeal blood purification platform expandable to other life-threatening conditions where explosive oxidative stress is the core pathology, including ARDS (Acute Respiratory Distress Syndrome), Post-Cardiac Arrest Syndrome (PCAS), and emerging infectious diseases.
Partner with Us
For investment or partnership opportunities, please reach out to us. We will evaluate your inquiry and follow up shortly.
Partner with Us
For investment or partnership opportunities, please reach out to us. We will evaluate your inquiry and follow up shortly.
Partner with Us
For investment or partnership opportunities, please reach out to us. We will evaluate your inquiry and follow up shortly.